Two breathing exercise methods for breathlessness and lung function in people with COPD
Compares coherent breathing with regular paced breathing in people with COPD.
Plain-language title generated from the registry record
Registry title: Comparative Effects of Coherent Breathing and Regular Paced Breathing on Dyspnea and Pulmonary Function in Patients With Chronic Obstructive Pulmonary Disease
Key facts
- Where
- Rawalpindi, PakistanSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 75 years old?
Source: NCT07875036, who can take part
Where in Pakistan
- Foundation University IslamabadRawalpindi, PakistanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Foundation University Islamabad
- Trial code
- NCT07875036
- Record updated
- 15 October 2026
- Original description
Chronic Obstructive Pulmonary Disease (COPD) is an inflammatory condition of airways characterized by recurrent episodes of coughing, respiratory muscle weakness, lung hyperinflation and air trapping which ultimately leads to dyspnea, impaired pulmonary function and reduced quality of life.Read full original descriptionShow less
Comparative Effects of Coherent Breathing and Regular Paced Breathing on Dyspnea and Pulmonary Function in Patients With Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease (COPD) is an inflammatory condition of airways characterized by recurrent episodes of coughing, respiratory muscle weakness, lung hyperinflation and air trapping which ultimately leads to dyspnea, impaired pulmonary function and reduced quality of life.
Non- pharmacological approaches, particularly breathing retraining techniques, have gained recognition as complementary strategies for optimizing COPD management by improving overall functional status and exercise tolerance in the patients.
Inclusion: Age between 40-75 years; Both genders (male and females); Diagnosed COPD mild to moderate stage according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification:; Mild: FEV1 ≥ 80% predicted Moderate: FEV1 fall between 50-79%; Diagnosed with COPD for at least 6 months prior to enrollment in study; Resting SpO₂ ≥ 90% on room air.
Exclusion: Other sgnificant respiratory diseases (e.g., asthma, bronchiectasis, ILD, active tuberculosis); Severe and very severe stage of COPD according to GOLD classification; Patients having acute exacerbation of COPD with in the last 4 weeks; Hemodnamically unstable patients; Current smokers (active smoking or individuals using any tobacco product within the 6 months); Patients unable to follow commands/instructions; Patients currently participating in any other structured pulmonary rehabilitation or breathing intervention program.